Bexion Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Bexion Pharmaceuticals's estimated annual revenue is currently $5.3M per year.
- Bexion Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Bexion Pharmaceuticals has 34 Employees.
- Bexion Pharmaceuticals grew their employee count by 6% last year.
Bexion Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and Chief Scientific Officer | Reveal Email/Phone |
2 | President & CEO | Reveal Email/Phone |
3 | President & CEO | Reveal Email/Phone |
4 | Chief Staff | Reveal Email/Phone |
5 | Chief Operations Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | VP Business Development | Reveal Email/Phone |
9 | VP | Reveal Email/Phone |
10 | VP Research & Development | Reveal Email/Phone |
Bexion Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $2.6M | 17 | 6% | N/A | N/A |
#4 | $4.3M | 28 | -32% | N/A | N/A |
#5 | $499.4M | 3222 | 3% | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $3.6M | 23 | 28% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $4M | 26 | 18% | N/A | N/A |
#10 | $31.8M | 205 | -14% | N/A | N/A |
What Is Bexion Pharmaceuticals?
Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. We focus on helping patients and their families living with cancer, where there is a significant unmet need. Bexion has initiated a robust clinical development plan to develop safe, effective treatments across multiple indications. Our company founder and leadership team have deep experience across pharmaceutical operations, discovery, research and development, manufacturing, clinical, regulatory, and commercialization. The Bexion team is driven by the promise of developing life-changing oncology therapies on our path to become a leading biotech company. Bexion has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for Glioblastoma Multiforme (GBM) and Malignant Glioma including Diffuse Intrinsic Pontine Giloma (DIPG) To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or contact Margaret M. van Gilse at (859) 446-7386 or mvangilse@bexionpharma.com
keywords:N/AN/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 34 | 3% | N/A |
#2 | $6.8M | 34 | -3% | N/A |
#3 | $9.2M | 35 | 6% | N/A |
#4 | $7.2M | 36 | 6% | N/A |
#5 | $9.4M | 36 | 3% | N/A |